Alx Oncology Holdings (ALXO) Revenue (2019 - 2020)
Alx Oncology Holdings' (ALXO) quarterly Revenue came in at $527000.0 in Q2 2020, down 59.31% year-on-year from $1.3 million in Q3 2019, and down 19.54% quarter-over-quarter from $655000.0 in Q1 2020.
Alx Oncology Holdings (ALXO) Revenue (2019 - 2020) Analysis & Trends
Alx Oncology Holdings has disclosed Revenue across 2 years of filings, most recently posting $527000.0 for Q2 2020.
- Revenue for Q2 2020 came in at $527000.0, down 59.31% year-over-year; the trailing twelve-month figure through Mar 2021 was $527000.0 (down 88.07% YoY), and the FY2020 annual result was $1.2 million, down 75.35% from the prior year.
- Revenue came in at $527000.0 for Q2 2020 at Alx Oncology Holdings, down from $655000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $1.3 million in Q2 2019 to a low of $527000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Alx Oncology Holdings | 159.47 Mn | 19.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 527,000.00 |
| Mar 31, 2020 | 655,000.00 |
| Dec 31, 2019 | 1.21 Mn |
| Sep 30, 2019 | 1.26 Mn |
| Jun 30, 2019 | 1.30 Mn |